AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
Previous product
Back to products
Glembatumumab
$307.00 – $1,095.00
Next product
Polatuzumab
$269.00 – $1,075.00
Catalog #: | AP15512 |
Name: | Brentuximab |
Molecular Weight: | |
CAS: | 2088770-90-3 |
Purity: | ≥98% |
Availability: | In Stock |
Brentuximab
$432.00 – $940.80
Brentuximab (CAS 2088770-90-3) is a monoclonal antibody targeting CD30 on cancer cells. Conjugated with monomethyl auristatin E (MMAE), it forms Brentuximab vedotin, which induces apoptosis in CD30+ cancer cells and shows strong antitumor activity.
Unit | Price | Quantity | |
---|---|---|---|
1 mg | $432 | ||
5 mg | $940.8 |
Would you like to inquire about bulk pricing?
SKU: AP15512
Categories: Antibody, Antibody and Antibody Drug Conjugate (ADC)
Shipping & Delivery
Ships within: 24 hours
Storage condition: -20 ° C
Shipping: Ambient Temperature
Storage condition: -20 ° C
Shipping: Ambient Temperature
Related products
Cat# | Name | Structure | M.W. | Purity | Pricing | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AP15518 | Vobramitamab | ≥99% | Pricing | ||||||||||||||||||
M.W: ; Purity: ≥99%
Inquire about bulk pricing for large orders! | |||||||||||||||||||||
AP15506 | Inebilizumab | ≥99% | Pricing | ||||||||||||||||||
M.W: ; Purity: ≥99%
Inquire about bulk pricing for large orders! | |||||||||||||||||||||
AP15523 | Izeltabart | ≥98% | Pricing | ||||||||||||||||||
M.W: ; Purity: ≥98%
Inquire about bulk pricing for large orders! | |||||||||||||||||||||
AP15504 | Enfortumab | ≥99% | Pricing | ||||||||||||||||||
M.W: ; Purity: ≥99%
Inquire about bulk pricing for large orders! | |||||||||||||||||||||
AP15527 | Moxetumomab | ≥95% | Pricing | ||||||||||||||||||
M.W: ; Purity: ≥95%
Inquire about bulk pricing for large orders! | |||||||||||||||||||||
AP15522 | Lorvotuzumab | ≥99% | Pricing | ||||||||||||||||||
M.W: ; Purity: ≥99%
Inquire about bulk pricing for large orders! |